Cocrystal Pharma Inc (COCP)
1.79
+0.06
(+3.47%)
USD |
NASDAQ |
Nov 04, 13:09
Cocrystal Pharma Shareholders Equity (Quarterly): 17.39M for June 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 17.39M |
March 31, 2024 | 22.58M |
December 31, 2023 | 26.38M |
September 30, 2023 | 30.69M |
June 30, 2023 | 34.68M |
March 31, 2023 | 34.67M |
December 31, 2022 | 39.57M |
September 30, 2022 | 43.91M |
June 30, 2022 | 49.39M |
March 31, 2022 | 73.58M |
December 31, 2021 | 77.55M |
September 30, 2021 | 81.01M |
June 30, 2021 | 84.75M |
March 31, 2021 | 52.06M |
December 31, 2020 | 52.50M |
September 30, 2020 | 50.18M |
June 30, 2020 | 37.06M |
March 31, 2020 | 40.43M |
December 31, 2019 | 25.71M |
September 30, 2019 | 70.74M |
June 30, 2019 | 72.42M |
March 31, 2019 | 73.82M |
December 31, 2018 | 66.89M |
September 30, 2018 | 110.90M |
June 30, 2018 | 112.65M |
Date | Value |
---|---|
March 31, 2018 | 104.14M |
December 31, 2017 | 105.40M |
September 30, 2017 | 100.00M |
June 30, 2017 | 102.04M |
March 31, 2017 | 99.98M |
December 31, 2016 | 102.32M |
September 30, 2016 | 167.82M |
June 30, 2016 | 166.83M |
March 31, 2016 | 169.34M |
December 31, 2015 | 167.59M |
September 30, 2015 | 196.75M |
June 30, 2015 | 196.52M |
March 31, 2015 | 188.70M |
December 31, 2014 | 6.651M |
September 30, 2014 | 3.978M |
June 30, 2014 | 6.056M |
March 31, 2014 | -2.074M |
December 31, 2013 | -8.833M |
September 30, 2013 | -10.45M |
June 30, 2013 | -5.308M |
March 31, 2013 | -5.056M |
December 31, 2012 | -3.580M |
September 30, 2012 | -0.0749M |
June 30, 2012 | -3.932M |
March 31, 2012 | -5.765M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
17.39M
Minimum
Jun 2024
84.75M
Maximum
Jun 2021
46.00M
Average
40.43M
Median
Mar 2020
Shareholders Equity (Quarterly) Benchmarks
Perspective Therapeutics Inc | 341.00M |
Alaunos Therapeutics Inc | 3.771M |
Oragenics Inc | 1.326M |
Cara Therapeutics Inc | 11.60M |
Jaguar Health Inc | 16.91M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 21.57M |
Total Liabilities (Quarterly) | 4.183M |